Pulmonary embolism and COVID-19
dc.contributor.author | Farrell, A. M. | |
dc.contributor.author | Walsh, L. J. | |
dc.contributor.author | Plant, Barry J. | |
dc.contributor.author | Henry, M. T. | |
dc.contributor.author | Kennedy, Marcus P. | |
dc.contributor.author | Eustace, Joseph A. | |
dc.contributor.author | Sadlier, C. | |
dc.contributor.author | Crowley, M. | |
dc.contributor.author | Murphy, Desmond M. | |
dc.date.accessioned | 2020-12-11T11:36:53Z | |
dc.date.available | 2020-12-11T11:36:53Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Aims: There is increasing concern amongst clinicians of a possible increase in venous thromboembolism (VTE) events in patients with COVID-19. There remains limited data defining the incidence of VTE in this population and thus also a paucity of research examining the impact of targeted treatment in patients with thrombotic complications. Methods: We examined the number of symptomatic VTE events amongst proven COVID-19 patients admitted to a tertiary level academic hospital, over a one-month period. Patient characteristics, admission and discharge inflammatory and coagulation markers were included in the analysis. Results: Sixty-one patients were identified. Twelve patients (19.6%) admitted with COVID-19 were treated for a suspected PE. Of these patients, 3 patients were discharged on anticoagulation, 3 died and 6 remain inpatients at the end of the study period. Discussion: COVID-19 patients are at increased risk of VTE. This risk may extend beyond the period of admission. Further research examining the role of extending the duration of thromboprophylaxis in COVID-19 patients beyond hospital discharge is warranted. | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | P162 | en |
dc.identifier.citation | Farrell, A. M., Walsh, L. J., Plant, B. J., Henry, M. T., Kennedy, M. P., Eustace, J .E., Sadlier, C., Crowley, M. and Murphy, D. M. (2020) 'Pulmonary embolism and COVID-19', Irish Medical Journal, 113(8), P162 (4pp). Available at: https://imj.ie/wp-content/uploads/2020/09/Pulmonary-Embolism-and-COVID-19.pdf (Accessed: 11 December 2020) | en |
dc.identifier.endpage | 4 | en |
dc.identifier.issn | 0332-3102 | |
dc.identifier.issued | 8 | en |
dc.identifier.journaltitle | Irish Medical Journal | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/10832 | |
dc.identifier.volume | 113 | en |
dc.language.iso | en | en |
dc.publisher | Irish Medical Organisation | en |
dc.relation.uri | https://imj.ie/irish-medical-journal-september-2020-vol-113-no-8/ | |
dc.relation.uri | http://imj.ie/pulmonary-embolism-and-covid-19/ | |
dc.rights | © 2020, Irish Medical Organisation. All rights reserved. | en |
dc.subject | COVID-19 | en |
dc.subject | VTE | en |
dc.subject | Venous thromboembolism | en |
dc.subject | Pulmonary embolus | en |
dc.subject | Anticoagulation | en |
dc.title | Pulmonary embolism and COVID-19 | en |
dc.type | Article (peer-reviewed) | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Pulmonary-Embolism-and-COVID-19.pdf
- Size:
- 132.18 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published Version
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 2.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: